Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |
mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |